Sign up
Pharma Capital

Zak Mir expects OptiBiotix to trade in current range for time being

OptiBiotix Health plc (LON:OPTI) shares have been trading in a range of between 60p and 85p for the past 18  months, and technical analyst Zak Mir expects that to continue in the short term.

“We can see that there’s been consolidation over the near term, basically in a range of between 60p and 85p,” explains Mir in the latest Proactive Investors Bulletin Board.

“The floor of that range has been in place for the past year and a half and we would expect that to continue for the near term.”


View full OPTI profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.